Aging: an emergent phenotypic trait that contributes to the virulence of Cryptococcus neoformans

Papers of special note have been highlighted as: • of interest; •• of considerable interest.

References

• 1 Smith ED, Kennedy BK, Kaeberlein M. Genome-wide identification of conserved longevity genes in yeast and worms. Mech. Ageing Dev. 128(1), 106–111 (2007).
  Medline CASGoogle Scholar
• 2 Kennedy BK, Guarente L. Genetic analysis of aging in Saccharomyces cerevisiae. Trends Genet. 12(9), 355–359 (1996).
  Medline CASGoogle Scholar
• 3 Kaeberlein M. Lessons on longevity from budding yeast. Nature 464(7288), 513–519 (2010).
  Medline CASGoogle Scholar
• 4 Roux AE, Quissac A, Chartrand P, Ferbeyre G, Rokeach LA. Regulation of chronological aging in Schizosaccharomyces pombe by the protein kinases Pka1 and Sck2. Aging Cell 5(4), 345–357 (2006).
  Medline CASGoogle Scholar
• 5 Roux AE, Chartrand P, Ferbeyre G, Rokeach LA. Fission yeast and other yeasts as emergent models to unravel cellular aging in eukaryotes. J. Gerontol. A. Biol. Sci. Med. Sci. 65(1), 1–8 (2010).
  MedlineGoogle Scholar
• 6 Jain N, Cook E, Xess I, Hasan F, Fries D, Fries BC. Isolation and characterization of senescent Cryptococcus neoformans and implications for phenotypic switching and pathogenesis in chronic cryptococcosis. Eukaryot. Cell 8(6), 858–866 (2009).•• This is the first major work to link replicative aging to a fungal pathogen and highlights the importance of studying this emerging variant.
  Medline CASGoogle Scholar
• 7 Cordero RJ, Pontes B, Guimaraes AJ et al. Chronological aging is associated with biophysical and chemical changes in the capsule of Cryptococcus neoformans. Infect. Immun. 79(12), 4990–5000 (2011).• This is the first major work to study chronological aging in C. neoformans and showcases the importance of aging to generate variation.
  Medline CASGoogle Scholar
• 8 Bouklas T, Pechuan X, Goldman DL, Edelman B, Bergman A, Fries BC. Old Cryptococcus neoformans cells contribute to virulence in chronic cryptococcosis. MBio 4(4), doi:10.1128/mBio.00455-13 (2013).•• This is the first study to show that old C. neoformans cells display a potentially advantageous phenotype in vitro and can accumulate in vivo.
  MedlineGoogle Scholar
• 9 Fu XH, Meng FL, Hu Y, Zhou JQ. Candida albicans, a distinctive fungal model for cellular aging study. Aging cell 7(5), 746–757 (2008).
  Medline CASGoogle Scholar
• 10 Gupta G, Fries BC. Variability of phenotypic traits in Cryptococcus varieties and species and the resulting implications for pathogenesis. Future Microbiol. 5(5), 775–787 (2010).
  Google Scholar
• 11 Pietrella D, Fries B, Lupo P, Bistoni F, Casadevall A, Vecchiarelli A. Phenotypic switching of Cryptococcus neoformans can influence the outcome of the human immune response. Cell. Microbiol. 5(8), 513–522 (2003).
  Medline CASGoogle Scholar
• 12 Guerrero A, Fries BC. Phenotypic switching in Cryptococcus neoformans contributes to virulence by changing the immunological host response. Infect. Immun. 76(9), 4322–4331 (2008).
  Medline CASGoogle Scholar
• 13 Mcfadden DC, Fries BC, Wang F, Casadevall A. Capsule structural heterogeneity and antigenic variation in Cryptococcus neoformans. Eukaryot. Cell 6(8), 1464–1473 (2007).
  Medline CASGoogle Scholar
• 14 Jain N, Guerrero A, Fries BC. Phenotypic switching and its implications for the pathogenesis of Cryptococcus neoformans. FEMS Yeast Res. 6(4), 480–488 (2006).
  Medline CASGoogle Scholar
• 15 Blasi E, Brozzetti A, Francisci D et al. Evidence of microevolution in a clinical case of recurrent Cryptococcus neoformans meningoencephalitis. Eur. J. Clin. Microbiol. Infect. Dis. 20(8), 535–543 (2001).
  Medline CASGoogle Scholar
• 16 Ormerod KL, Morrow CA, Chow EW et al. Comparative genomics of serial isolates of Cryptococcus neoformans reveals gene associated with carbon utilization and virulence. G3 (Bethesda) doi:10.1534/g3.113.005660 (2013) (Epub ahead of print).
  MedlineGoogle Scholar
• 17 Fries BC, Casadevall A. Serial isolates of Cryptococcus neoformans from patients with AIDS differ in virulence for mice. J. Infect. Dis. 178(6), 1761–1766 (1998).
  Medline CASGoogle Scholar
• 18 Cherniak R, Morris LC, Belay T, Spitzer ED, Casadevall A. Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent Cryptococcal meningitis. Infect. Immun. 63(5), 1899–1905 (1995).
  Medline CASGoogle Scholar
• 19 Zaragoza O, Taborda CP, Casadevall A. The efficacy of complement-mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirect C3-mediated interactions. Eur. J. Immunol. 33(7), 1957–1967 (2003).
  Medline CASGoogle Scholar
• 20 Garcia-Hermoso D, Dromer F, Janbon G. Cryptococcus neoformans capsule structure evolution in vitro and during murine infection. Infect. Immun. 72(6), 3359–3365 (2004).
  Medline CASGoogle Scholar
• 21 Garcia-Rodas R, Cordero RJ, Trevijano-Contador N et al. Capsule growth in Cryptococcus neoformans is coordinated with cell cycle progression. MBio 5(3), e00945–e00914 (2014).
  MedlineGoogle Scholar
• 22 Martín JP, Di Pietro A. Morphogenesis and Pathogenicity in Fungi. Springer, NY, USA (2012).
  Google Scholar
• 23 O'meara TR, Norton D, Price MS et al. Interaction of Cryptococcus neoformans Rim101 and protein kinase A regulates capsule. PLoS Pathog. 6(2), e1000776 (2010).
  MedlineGoogle Scholar
• 24 Liu OW, Chun CD, Chow ED, Chen C, Madhani HD, Noble SM. Systematic genetic analysis of virulence in the human fungal pathogen Cryptococcus neoformans. Cell 135(1), 174–188 (2008).
  Medline CASGoogle Scholar
• 25 Rivera J, Feldmesser M, Cammer M, Casadevall A. Organ-dependent variation of capsule thickness in Cryptococcus neoformans during experimental murine infection. Infect. Immun. 66(10), 5027–5030 (1998).
  Medline CASGoogle Scholar
• 26 Vartivarian SE, Anaissie EJ, Cowart RE, Sprigg HA, Tingler MJ, Jacobson ES. Regulation of cryptococcal capsular polysaccharide by iron. J. Infect. Dis. 167(1), 186–190 (1993).
  Medline CASGoogle Scholar
• 27 Charlier C, Nielsen K, Daou S, Brigitte M, Chretien F, Dromer F. Evidence of a role for monocytes in dissemination and brain invasion by Cryptococcus neoformans. Infect. Immun. 77(1), 120–127 (2009).
  Medline CASGoogle Scholar
• 28 Shi M, Li SS, Zheng C et al. Real-time imaging of trapping and urease-dependent transmigration of Cryptococcus neoformans in mouse brain. J. Clin. Invest. 120(5), 1683–1693 (2010).
  Medline CASGoogle Scholar
• 29 Sabiiti W, Robertson E, Beale MA et al. Efficient phagocytosis and laccase activity affect the outcome of HIV-associated cryptococcosis. J. Clin. Invest. 124(5), 2000–2008 (2014).
  Medline CASGoogle Scholar
• 30 Feldmesser M, Kress Y, Casadevall A. Dynamic changes in the morphology of Cryptococcus neoformans during murine pulmonary infection. Microbiology 147(Pt 8), 2355–2365 (2001).
  Medline CASGoogle Scholar
• 31 Cordero RJ, Bergman A, Casadevall A. Temporal behavior of capsule enlargement by Cryptococcus neoformans. Eukaryot. Cell 12(10), 1383–1388 (2013).
  Medline CASGoogle Scholar
• 32 Yang J, Dungrawala H, Hua H et al. Cell size and growth rate are major determinants of replicative lifespan. Cell Cycle 10(1), 144–155 (2011).
  Medline CASGoogle Scholar
• 33 Aldridge BB, Fernandez-Suarez M, Heller D et al. Asymmetry and aging of mycobacterial cells lead to variable growth and antibiotic susceptibility. Science 335(6064), 100–104 (2012).• This study links aging to prokaryotic pathogen and is important in showcasing the universality of this trait in generating variation in pathogens.
  Medline CASGoogle Scholar
• 34 Feldmesser M, Kress Y, Novikoff P, Casadevall A. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect. Immun. 68(7), 4225–4237 (2000).
  Medline CASGoogle Scholar
• 35 Goldman DL, Lee SC, Mednick AJ, Montella L, Casadevall A. Persistent Cryptococcus neoformans pulmonary infection in the rat is associated with intracellular parasitism, decreased inducible nitric oxide synthase expression, and altered antibody responsiveness to cryptococcal polysaccharide. Infect. Immun. 68(2), 832–838 (2000).
  Medline CASGoogle Scholar
• 36 Steenbergen JN, Shuman HA, Casadevall A. Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages. Proc. Natl Acad. Sci. USA 98(26), 15245–15250 (2001).
  Medline CASGoogle Scholar
• 37 Feldmesser M, Tucker S, Casadevall A. Intracellular parasitism of macrophages by Cryptococcus neoformans. Trends Microbiol. 9(6), 273–278 (2001).
  Medline CASGoogle Scholar
• 38 Coelho C, Bocca AL, Casadevall A. The intracellular life of Cryptococcus neoformans. Annu. Rev. Pathol. 9, 219–238 (2014).
  Medline CASGoogle Scholar
• 39 Zaragoza O, Nielsen K. Titan cells in Cryptococcus neoformans: cells with a giant impact. Curr. Opin. Microbiol. 16(4), 409–413 (2013).•• This study highlights cell size as important to generating variants that can have significant consequences for cryptococcal virulence and infection.
  Medline CASGoogle Scholar
• 40 Okagaki LH, Nielsen K. Titan cells confer protection from phagocytosis in Cryptococcus neoformans infections. Eukaryot. Cell 11(6), 820–826 (2012).
  Medline CASGoogle Scholar
• 41 Kondorosi E, Roudier F, Gendreau E. Plant cell-size control: growing by ploidy? Curr. Opin. Plant. Biol. 3(6), 488–492 (2000).
  Medline CASGoogle Scholar
• 42 Mansour MK, Schlesinger LS, Levitz SM. Optimal T cell responses to Cryptococcus neoformans mannoprotein are dependent on recognition of conjugated carbohydrates by mannose receptors. J. Immunol. 168(6), 2872–2879 (2002).
  Medline CASGoogle Scholar
• 43 Levitz SM, Specht CA. The molecular basis for the immunogenicity of Cryptococcus neoformans mannoproteins. FEMS Yeast Res. 6(4), 513–524 (2006).
  Medline CASGoogle Scholar
• 44 Levitz SM. Innate recognition of fungal cell walls. PLoS Pathog. 6(4), e1000758 (2010).
  MedlineGoogle Scholar
• 45 Baker LG, Specht CA, Donlin MJ, Lodge JK. Chitosan, the deacetylated form of chitin, is necessary for cell wall integrity in Cryptococcus neoformans. Eukaryot. Cell 6(5), 855–867 (2007).
  Medline CASGoogle Scholar
• 46 Baker LG, Specht CA, Lodge JK. Cell wall chitosan is necessary for virulence in the opportunistic pathogen Cryptococcus neoformans. Eukaryot. Cell 10(9), 1264–1268 (2011).
  Medline CASGoogle Scholar
• 47 Sinclair D, Mills K, Guarente L. Aging in Saccharomyces cerevisiae. Annu. Rev. Microbiol. 52, 533–560 (1998).
  Medline CASGoogle Scholar
• 48 Powell CD, Quain DE, Smart KA. Chitin scar breaks in aged Saccharomyces cerevisiae. Microbiology 149(Pt 11), 3129–3137 (2003).
  Medline CASGoogle Scholar
• 49 Zaragoza O, Telzak A, Bryan RA, Dadachova E, Casadevall A. The polysaccharide capsule of the pathogenic fungus Cryptococcus neoformans enlarges by distal growth and is rearranged during budding. Mol. Microbiol. 59(1), 67–83 (2006).
  Medline CASGoogle Scholar
• 50 Mcfadden D, Zaragoza O, Casadevall A. The capsular dynamics of Cryptococcus neoformans. Trends Microbiol. 14(11), 497–505 (2006).
  Medline CASGoogle Scholar
• 51 Bicanic T, Meintjes G, Wood R et al. Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole. Clin. Infect. Dis. 45(1), 76–80 (2007).
  Medline CASGoogle Scholar
• 52 Bicanic T, Brouwer AE, Meintjes G et al. Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures. AIDS 23(6), 701–706 (2009).• This study made use of serial isolates to demonstrate treatment failure as established by a measure of ‘effective fungicidal activity.’
  MedlineGoogle Scholar
• 53 Jain N, Wickes BL, Keller SM et al. Molecular epidemiology of clinical Cryptococcus neoformans strains from India. J. Clin. Microbiol. 43(11), 5733–5742 (2005).
  Medline CASGoogle Scholar
• 54 Slutsky B, Buffo J, Soll DR. High-frequency switching of colony morphology in Candida albicans. Science 230(4726), 666–669 (1985).
  Medline CASGoogle Scholar
• 55 Fries BC, Goldman DL, Cherniak R, Ju R, Casadevall A. Phenotypic switching in Cryptococcus neoformans results in changes in cellular morphology and glucuronoxylomannan structure. Infect. Immun. 67(11), 6076–6083 (1999).
  Medline CASGoogle Scholar
• 56 Fries BC, Taborda CP, Serfass E, Casadevall A. Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection. J. Clin. Invest. 108(11), 1639–1648 (2001).
  Medline CASGoogle Scholar
• 57 Goldman DL, Fries BC, Franzot SP, Montella L, Casadevall A. Phenotypic switching in the human pathogenic fungus Cryptococcus neoformans is associated with changes in virulence and pulmonary inflammatory response in rodents. Proc. Natl Acad. Sci. USA 95(25), 14967–14972 (1998).
  Medline CASGoogle Scholar
• 58 Jain N, Li L, Mcfadden DC et al. Phenotypic switching in a Cryptococcus neoformans variety gattii strain is associated with changes in virulence and promotes dissemination to the central nervous system. Infect. Immun. 74(2), 896–903 (2006).
  Medline CASGoogle Scholar
• 59 Jain N, Li L, Hsueh YP et al. Loss of allergen 1 confers a hypervirulent phenotype that resembles mucoid switch variants of Cryptococcus neoformans. Infect. Immun. 77(1), 128–140 (2009).
  Medline CASGoogle Scholar
• 60 Guerrero A, Jain N, Wang X, Fries BC. Cryptococcus neoformans variants generated by phenotypic switching differ in virulence through effects on macrophage activation. Infect. Immun. 78(3), 1049–1057 (2010).
  Medline CASGoogle Scholar
• 61 Srikantha T, Zhao R, Daniels K, Radke J, Soll DR. Phenotypic switching in Candida glabrata accompanied by changes in expression of genes with deduced functions in copper detoxification and stress. Eukaryot. Cell 4(8), 1434–1445 (2005).
  Medline CASGoogle Scholar
• 62 Lachke SA, Joly S, Daniels K, Soll DR. Phenotypic switching and filamentation in Candida glabrata. Microbiology 148(Pt 9), 2661–2674 (2002).
  Medline CASGoogle Scholar
• 63 Gravel S, Jackson SP. Increased genome instability in aging yeast. Cell 115(1), 1–2 (2003).
  Medline CASGoogle Scholar
• 64 Mcmurray MA, Gottschling DE. An age-induced switch to a hyper-recombinational state. Science 301(5641), 1908–1911 (2003).
  Medline CASGoogle Scholar
• 65 Sionov E, Lee H, Chang YC, Kwon-Chung KJ. Cryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomes. PLoS Pathog. 6(4), e1000848 (2010).
  MedlineGoogle Scholar
• 66 Ormerod KL, Fraser JA. Balancing stability and flexibility within the genome of the pathogen Cryptococcus neoformans. PLoS Pathog. 9(12), e1003764 (2013).
  MedlineGoogle Scholar
• 67 Hu G, Wang J, Choi J et al. Variation in chromosome copy number influences the virulence of Cryptococcus neoformans and occurs in isolates from AIDS patients. BMC Genomics 12, 526 (2011).
  Medline CASGoogle Scholar
• 68 Li W, Averette AF, Desnos-Ollivier M, Ni M, Dromer F, Heitman J. Genetic diversity and genomic plasticity of Cryptococcus neoformans AD hybrid strains. G3 (Bethesda) 2(1), 83–97 (2012).
  Medline CASGoogle Scholar
• 69 Delaney JR, Murakami CJ, Olsen B, Kennedy BK, Kaeberlein M. Quantitative evidence for early life fitness defects from 32 longevity-associated alleles in yeast. Cell Cycle 10(1), 156–165 (2011).
  Medline CASGoogle Scholar
• 70 Kennedy BK, Austriaco NR Jr, Guarente L. Daughter cells of Saccharomyces cerevisiae from old mothers display a reduced life span. J. Cell Biol. 127(6 Pt 2), 1985–1993 (1994).
  Medline CASGoogle Scholar
• 71 Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23(4), 525–530 (2009).
  MedlineGoogle Scholar
• 72 Robertson EJ, Najjuka G, Rolfes MA et al. Cryptococcus neoformansex vivo capsule size is associated with intracranial pressure and host immune response in HIV-associated cryptococcal meningitis. J. Infect. Dis. 209(1), 74–82 (2014).•• This study demonstrated that the pathogen population in vivo is more heterogeneous in capsule size, which invariably affects intracranial pressure and inflammatory response in the patient.
  Medline CASGoogle Scholar